Research continues to link statin therapy to CoQ10 losses.
New cholesterol treatment guidelines proposed by the American Heart Association could very well double the amount of U.S. consumers who take statins. But more statin use may also mean more sales of coenzyme Q10 (CoQ10) supplements-because research continues to link statin therapy to low CoQ10 levels.
The body uses CoQ10 for energy and cell growth, and as an antioxidant.
To assess the effect of CoQ10 supplements on statin users, Taiwanese researchers recruited 51 statin users with coronary artery disease and assigned them to a daily CoQ10 supplement or placebo for 12 weeks. In as little as four weeks, CoQ10 levels increased five-fold in the supplemented group compared to placebo. Markers of inflammation also improved, and vitamin E levels increased in proportion to increases in blood CoQ10.
With their new findings reassuring them, the researchers state that CoQ10 appears intimately related to vitamin E because it “not only protects vitamin E against superoxide-driven oxidation, but also regenerates vitamin E during antioxidation processes.”
The researchers designed their study with a daily dose of 300 g of CoQ10, because their previous trial on 150 mg could not induce anti-inflammatory benefit. Both doses, however, did improve CoQ10 blood status.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.